Hims & Hers to launch AI agent for weight-loss journey as GLP-1 landscape shifts
CTO Mo Elshenawy unveiled the AI agent strategy on the Q1 earnings call, positioning the platform to guide patients through weight-loss programs as GLP-1 drug availability and regulation evolve. The move deepens Hims & Hers' bet on tech-enabled personalization in a category under pressure.
Hims & Hers will launch an AI agent for the weight-loss journey, leveraging its tech platform to adapt to shifts in GLP-1 drug availability. CTO Mo Elshenawy outlined the AI strategy during the Q1 earnings call.